Jacques Robert
Concepts (284)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Xenopus laevis | 25 | 1988 | 49 |
Why?
| Xenopus | 30 | 1990 | 37 |
Why?
| Antigens, Neoplasm | 12 | 1998 | 56 |
Why?
| Ranavirus | 7 | 2005 | 5 |
Why?
| Xenopus Proteins | 14 | 1996 | 15 |
Why?
| Histocompatibility Antigens Class I | 10 | 1995 | 32 |
Why?
| CD8-Positive T-Lymphocytes | 9 | 1999 | 91 |
Why?
| Phylogeny | 12 | 1999 | 63 |
Why?
| DNA Virus Infections | 5 | 2003 | 2 |
Why?
| Immune System | 4 | 2003 | 43 |
Why?
| Heat-Shock Proteins | 6 | 1998 | 38 |
Why?
| Animals | 56 | 1988 | 1032 |
Why?
| Conserved Sequence | 5 | 1999 | 73 |
Why?
| Immunity, Innate | 4 | 2004 | 60 |
Why?
| Larva | 14 | 1991 | 20 |
Why?
| T-Lymphocytes | 6 | 1995 | 182 |
Why?
| Neoplasms, Experimental | 5 | 1995 | 72 |
Why?
| Membrane Proteins | 7 | 1996 | 233 |
Why?
| Cytotoxicity, Immunologic | 4 | 2002 | 54 |
Why?
| Leukocytes | 3 | 2004 | 94 |
Why?
| Biological Evolution | 6 | 1998 | 32 |
Why?
| HSP70 Heat-Shock Proteins | 3 | 2001 | 27 |
Why?
| Evolution, Molecular | 5 | 2008 | 46 |
Why?
| Thymus Gland | 6 | 1992 | 57 |
Why?
| Thymus Neoplasms | 4 | 1997 | 12 |
Why?
| Cell Differentiation | 6 | 1997 | 262 |
Why?
| Neoplasms | 4 | 1998 | 239 |
Why?
| Minor Histocompatibility Antigens | 5 | 2002 | 5 |
Why?
| Physiology, Comparative | 2 | 2010 | 3 |
Why?
| Skin Transplantation | 4 | 2001 | 40 |
Why?
| HSP90 Heat-Shock Proteins | 2 | 2003 | 11 |
Why?
| Gene Expression Regulation | 3 | 2001 | 279 |
Why?
| Neoplasm Transplantation | 7 | 1992 | 67 |
Why?
| Membrane Glycoproteins | 2 | 1999 | 154 |
Why?
| Receptors, Antigen, T-Cell | 2 | 2003 | 34 |
Why?
| B-Lymphocytes | 3 | 2000 | 134 |
Why?
| Eukaryotic Initiation Factor-2 | 1 | 2011 | 6 |
Why?
| Genes, Immediate-Early | 1 | 2011 | 10 |
Why?
| Water Microbiology | 1 | 2011 | 13 |
Why?
| Gene Knockout Techniques | 1 | 2011 | 16 |
Why?
| Vertebrates | 2 | 2010 | 14 |
Why?
| Amphibians | 1 | 2010 | 4 |
Why?
| Killer Cells, Natural | 4 | 2002 | 62 |
Why?
| Antigens, CD4 | 1 | 2010 | 29 |
Why?
| Tumor Escape | 1 | 2010 | 3 |
Why?
| Invertebrates | 1 | 2010 | 3 |
Why?
| Adaptive Immunity | 1 | 2010 | 5 |
Why?
| Antigens, Surface | 4 | 1996 | 51 |
Why?
| Cell Lineage | 2 | 2000 | 60 |
Why?
| Histocompatibility Antigens | 4 | 1997 | 17 |
Why?
| Viral Proteins | 1 | 2011 | 71 |
Why?
| Adoptive Transfer | 2 | 2004 | 16 |
Why?
| Cytidine Deaminase | 2 | 2006 | 15 |
Why?
| Immunologic Memory | 2 | 2006 | 51 |
Why?
| T-Lymphocyte Subsets | 2 | 1999 | 70 |
Why?
| Virus Replication | 1 | 2011 | 90 |
Why?
| Major Histocompatibility Complex | 6 | 1992 | 23 |
Why?
| Macrophages | 2 | 2007 | 148 |
Why?
| Low Density Lipoprotein Receptor-Related Protein-1 | 2 | 2004 | 6 |
Why?
| LDL-Receptor Related Protein-Associated Protein | 1 | 2008 | 2 |
Why?
| Cross-Priming | 1 | 2008 | 3 |
Why?
| Amino Acid Sequence | 11 | 1990 | 319 |
Why?
| Histocompatibility Antigens Class II | 3 | 2001 | 50 |
Why?
| Receptors, Antigen, B-Cell | 1 | 2007 | 12 |
Why?
| Gene Expression Profiling | 5 | 2009 | 138 |
Why?
| T-Lymphocytes, Cytotoxic | 3 | 2001 | 52 |
Why?
| Tumor Cells, Cultured | 8 | 1992 | 233 |
Why?
| Antigens, Bacterial | 1 | 2007 | 44 |
Why?
| Molecular Sequence Data | 12 | 1990 | 404 |
Why?
| Disease Models, Animal | 1 | 2011 | 349 |
Why?
| Isoantigens | 1 | 2007 | 18 |
Why?
| Antigens, Viral | 1 | 2007 | 53 |
Why?
| Gene Expression Regulation, Enzymologic | 1 | 2007 | 104 |
Why?
| Antigens, CD | 1 | 2008 | 128 |
Why?
| Creatine Kinase | 3 | 1988 | 37 |
Why?
| Animal Diseases | 1 | 2005 | 3 |
Why?
| Gene Expression Regulation, Developmental | 1 | 2007 | 119 |
Why?
| Gene Expression | 6 | 1990 | 291 |
Why?
| Models, Animal | 3 | 2004 | 85 |
Why?
| Iridoviridae | 1 | 2003 | 2 |
Why?
| Bacterial Physiological Phenomena | 1 | 2003 | 7 |
Why?
| Spleen | 4 | 2004 | 129 |
Why?
| Metamorphosis, Biological | 3 | 1991 | 4 |
Why?
| Sequence Homology, Amino Acid | 6 | 1996 | 156 |
Why?
| Antigens, Differentiation, T-Lymphocyte | 6 | 1996 | 23 |
Why?
| Antibodies, Viral | 1 | 2005 | 104 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 6 | 2003 | 243 |
Why?
| Flow Cytometry | 5 | 1995 | 216 |
Why?
| Adjuvants, Immunologic | 1 | 2003 | 73 |
Why?
| Genes, Immunoglobulin | 3 | 1995 | 28 |
Why?
| Genetic Predisposition to Disease | 3 | 2003 | 132 |
Why?
| CD4-Positive T-Lymphocytes | 2 | 1999 | 113 |
Why?
| Base Sequence | 6 | 1990 | 371 |
Why?
| Genome | 2 | 2009 | 30 |
Why?
| Multigene Family | 2 | 2009 | 52 |
Why?
| Mycoses | 2 | 2009 | 22 |
Why?
| Immunization | 3 | 2002 | 85 |
Why?
| Mammals | 2 | 2007 | 47 |
Why?
| Up-Regulation | 3 | 2003 | 183 |
Why?
| Endoplasmic Reticulum | 1 | 1999 | 59 |
Why?
| Models, Immunological | 1 | 1998 | 40 |
Why?
| Thymectomy | 2 | 1997 | 11 |
Why?
| Cell Transformation, Neoplastic | 2 | 2009 | 86 |
Why?
| Transplantation Immunology | 1 | 1997 | 19 |
Why?
| Graft Rejection | 3 | 1995 | 59 |
Why?
| Gene Rearrangement, B-Lymphocyte | 2 | 1995 | 13 |
Why?
| Neutralization Tests | 2 | 2005 | 37 |
Why?
| Immune Tolerance | 1 | 1997 | 72 |
Why?
| Cell Cycle | 1 | 1997 | 121 |
Why?
| Cell Line, Tumor | 2 | 2007 | 209 |
Why?
| Lymphocytes | 2 | 2003 | 142 |
Why?
| Blotting, Northern | 3 | 1990 | 152 |
Why?
| Antibodies, Monoclonal | 6 | 1991 | 242 |
Why?
| Lymphoma, B-Cell | 1 | 1995 | 33 |
Why?
| Cell Line | 4 | 2003 | 375 |
Why?
| Gamma Rays | 2 | 1995 | 38 |
Why?
| Protein Binding | 2 | 2003 | 256 |
Why?
| Immunoglobulin Class Switching | 3 | 2000 | 17 |
Why?
| Lymphoma | 1 | 1994 | 96 |
Why?
| Puromycin | 1 | 2011 | 10 |
Why?
| Selection, Genetic | 1 | 2011 | 11 |
Why?
| Animal Structures | 1 | 2011 | 2 |
Why?
| Kidney | 2 | 2003 | 223 |
Why?
| Protein Synthesis Inhibitors | 1 | 2011 | 33 |
Why?
| Antigen-Presenting Cells | 2 | 2001 | 40 |
Why?
| Mutagenesis, Insertional | 1 | 2011 | 37 |
Why?
| Ambystoma mexicanum | 1 | 2010 | 1 |
Why?
| Sequence Alignment | 2 | 1996 | 114 |
Why?
| Staining and Labeling | 1 | 2011 | 101 |
Why?
| Rana pipiens | 1 | 2010 | 8 |
Why?
| Antineoplastic Agents | 1 | 1997 | 191 |
Why?
| Virulence | 1 | 2011 | 48 |
Why?
| Protein Structure, Quaternary | 1 | 2010 | 18 |
Why?
| Viral Load | 1 | 2011 | 53 |
Why?
| Muscle Development | 1 | 1991 | 16 |
Why?
| Virulence Factors | 1 | 2011 | 24 |
Why?
| Regeneration | 1 | 2011 | 27 |
Why?
| Genes, Reporter | 1 | 2011 | 111 |
Why?
| Immunologic Surveillance | 1 | 2010 | 3 |
Why?
| Zygote | 1 | 1990 | 2 |
Why?
| Green Fluorescent Proteins | 1 | 2011 | 105 |
Why?
| Peptides | 2 | 2002 | 154 |
Why?
| Peritoneum | 1 | 2010 | 14 |
Why?
| Chytridiomycota | 1 | 2009 | 1 |
Why?
| Microscopy | 1 | 2010 | 31 |
Why?
| Receptors, KIR | 1 | 2009 | 1 |
Why?
| Antigen Presentation | 1 | 2010 | 28 |
Why?
| Tissue Transplantation | 1 | 2009 | 6 |
Why?
| Sequence Analysis, DNA | 1 | 2010 | 111 |
Why?
| Temperature | 1 | 2009 | 137 |
Why?
| Survival Analysis | 1 | 2011 | 206 |
Why?
| Lymphocyte Activation | 2 | 1999 | 137 |
Why?
| Macrophages, Peritoneal | 1 | 2008 | 12 |
Why?
| Immunophenotyping | 2 | 1995 | 66 |
Why?
| Somatic Hypermutation, Immunoglobulin | 1 | 2007 | 8 |
Why?
| Germinal Center | 1 | 2007 | 14 |
Why?
| Disease Reservoirs | 1 | 2007 | 7 |
Why?
| Cell Membrane | 2 | 1999 | 170 |
Why?
| Carrier State | 1 | 2007 | 20 |
Why?
| beta 2-Microglobulin | 1 | 2007 | 17 |
Why?
| Cell Division | 3 | 1992 | 273 |
Why?
| Immunohistochemistry | 2 | 1992 | 356 |
Why?
| Protein Subunits | 2 | 2003 | 44 |
Why?
| Whole-Body Irradiation | 1 | 2007 | 43 |
Why?
| Transfection | 2 | 2007 | 237 |
Why?
| Virus Diseases | 1 | 2007 | 50 |
Why?
| Immunocompromised Host | 1 | 2007 | 70 |
Why?
| Cross-Linking Reagents | 2 | 1997 | 38 |
Why?
| Capsid Proteins | 1 | 2006 | 19 |
Why?
| RNA Interference | 1 | 2007 | 75 |
Why?
| Bacterial Infections | 1 | 2007 | 88 |
Why?
| Liver | 2 | 2007 | 249 |
Why?
| Recombination, Genetic | 1 | 2007 | 78 |
Why?
| Enzyme Activation | 1 | 2007 | 177 |
Why?
| RNA, Viral | 1 | 2007 | 91 |
Why?
| DNA, Viral | 1 | 2006 | 98 |
Why?
| Polymerase Chain Reaction | 1 | 2007 | 279 |
Why?
| Humans | 8 | 1998 | 1858 |
Why?
| Transcription, Genetic | 1 | 2009 | 253 |
Why?
| Lymphocyte Depletion | 1 | 2005 | 29 |
Why?
| Clonal Deletion | 2 | 1996 | 6 |
Why?
| Cell Proliferation | 1 | 2007 | 227 |
Why?
| Homozygote | 1 | 2003 | 68 |
Why?
| Escherichia coli | 2 | 2003 | 143 |
Why?
| Aeromonas hydrophila | 1 | 2003 | 2 |
Why?
| Receptors, IgG | 1 | 2003 | 30 |
Why?
| Kinetics | 1 | 2007 | 349 |
Why?
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2002 | 4 |
Why?
| Isoenzymes | 3 | 1988 | 144 |
Why?
| Time Factors | 1 | 2010 | 896 |
Why?
| Cytotoxicity Tests, Immunologic | 1 | 2002 | 23 |
Why?
| Lymphoid Tissue | 2 | 1998 | 34 |
Why?
| Genotype | 1 | 2003 | 175 |
Why?
| Ionomycin | 1 | 2001 | 12 |
Why?
| Animals, Outbred Strains | 1 | 2001 | 9 |
Why?
| DNA Nucleotidylexotransferase | 1 | 2001 | 11 |
Why?
| Genes, MHC Class I | 1 | 2001 | 11 |
Why?
| Antigens, CD5 | 1 | 2001 | 11 |
Why?
| Antigens, CD8 | 1 | 2001 | 25 |
Why?
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2001 | 18 |
Why?
| Antigens, CD45 | 1 | 2001 | 30 |
Why?
| Lipopolysaccharides | 1 | 2003 | 98 |
Why?
| Genes, MHC Class II | 1 | 2001 | 17 |
Why?
| Aging | 1 | 2007 | 275 |
Why?
| Tetradecanoylphorbol Acetate | 1 | 2001 | 83 |
Why?
| Embryo, Nonmammalian | 2 | 1991 | 29 |
Why?
| Phenotype | 2 | 1999 | 304 |
Why?
| Hagfishes | 1 | 1999 | 1 |
Why?
| Ictaluridae | 1 | 1999 | 1 |
Why?
| Homeodomain Proteins | 1 | 2001 | 53 |
Why?
| Lymphocyte Subsets | 1 | 1999 | 26 |
Why?
| RNA, Messenger | 1 | 2007 | 394 |
Why?
| Fibroblasts | 1 | 2003 | 179 |
Why?
| Macromolecular Substances | 2 | 1988 | 92 |
Why?
| Chickens | 2 | 2009 | 82 |
Why?
| Mice | 4 | 1996 | 623 |
Why?
| Ovary | 2 | 1988 | 50 |
Why?
| Muscles | 2 | 1988 | 111 |
Why?
| Antigen-Antibody Reactions | 1 | 1997 | 32 |
Why?
| G2 Phase | 1 | 1997 | 20 |
Why?
| Oligonucleotide Array Sequence Analysis | 2 | 2009 | 135 |
Why?
| Glycosylation | 1 | 1997 | 37 |
Why?
| Electrophoresis, Gel, Two-Dimensional | 1 | 1997 | 42 |
Why?
| Mitosis | 1 | 1997 | 68 |
Why?
| Blotting, Southern | 2 | 2003 | 69 |
Why?
| Microtubules | 1 | 1997 | 38 |
Why?
| Surface Properties | 1 | 1997 | 64 |
Why?
| Dimerization | 1 | 1997 | 92 |
Why?
| Gene Rearrangement, B-Lymphocyte, Light Chain | 1 | 1995 | 3 |
Why?
| Antibodies, Neoplasm | 1 | 1995 | 28 |
Why?
| Gene Rearrangement, B-Lymphocyte, Heavy Chain | 1 | 1995 | 11 |
Why?
| DNA Replication | 1 | 1997 | 76 |
Why?
| Female | 5 | 1988 | 1646 |
Why?
| Cells, Cultured | 1 | 2002 | 447 |
Why?
| Cell Survival | 1 | 1997 | 230 |
Why?
| Genes | 2 | 1996 | 82 |
Why?
| Cell Transplantation | 1 | 1994 | 20 |
Why?
| DNA, Complementary | 2 | 1996 | 139 |
Why?
| Cell Nucleus | 1 | 1997 | 169 |
Why?
| Age Factors | 1 | 1995 | 480 |
Why?
| Immunoglobulins | 1 | 1992 | 54 |
Why?
| Karyotyping | 1 | 1992 | 47 |
Why?
| Synteny | 1 | 2010 | 3 |
Why?
| Organ Specificity | 1 | 1991 | 104 |
Why?
| Gene Duplication | 1 | 2010 | 7 |
Why?
| Expressed Sequence Tags | 1 | 2010 | 13 |
Why?
| Apoptosis | 1 | 1997 | 265 |
Why?
| Molecular Probe Techniques | 1 | 1990 | 9 |
Why?
| Immunoblotting | 1 | 1991 | 120 |
Why?
| DNA Transposable Elements | 1 | 2010 | 23 |
Why?
| Chromosomes | 1 | 2010 | 32 |
Why?
| Data Mining | 1 | 2009 | 3 |
Why?
| Cytoplasm | 1 | 1991 | 108 |
Why?
| Calcium | 1 | 1997 | 210 |
Why?
| Host-Pathogen Interactions | 1 | 2009 | 15 |
Why?
| Chromosome Mapping | 1 | 2010 | 107 |
Why?
| Computational Biology | 1 | 2010 | 40 |
Why?
| Electrophoresis, Cellulose Acetate | 1 | 1988 | 2 |
Why?
| Peptide Mapping | 1 | 1988 | 27 |
Why?
| Protein Multimerization | 1 | 1988 | 17 |
Why?
| Molecular Weight | 1 | 1988 | 155 |
Why?
| Cytosol | 1 | 1988 | 79 |
Why?
| Mutation | 2 | 2000 | 340 |
Why?
| Takifugu | 1 | 2006 | 7 |
Why?
| Nuclear Export Signals | 1 | 2006 | 7 |
Why?
| Skin | 1 | 2009 | 177 |
Why?
| NIH 3T3 Cells | 1 | 2006 | 22 |
Why?
| Catalytic Domain | 1 | 2006 | 27 |
Why?
| Reproducibility of Results | 1 | 2009 | 392 |
Why?
| Cloning, Molecular | 1 | 2006 | 183 |
Why?
| Recombinant Fusion Proteins | 1 | 2006 | 189 |
Why?
| Male | 2 | 1992 | 1558 |
Why?
| Models, Biological | 1 | 2009 | 411 |
Why?
| Precipitin Tests | 1 | 2003 | 81 |
Why?
| Complementarity Determining Regions | 1 | 2000 | 5 |
Why?
| Antibody Formation | 1 | 2000 | 90 |
Why?
| Gene Rearrangement, T-Lymphocyte | 1 | 1996 | 4 |
Why?
| Consensus Sequence | 1 | 1996 | 39 |
Why?
| Exons | 1 | 1996 | 91 |
Why?
| Protein Conformation | 1 | 1996 | 123 |
Why?
| Polymorphism, Genetic | 1 | 1996 | 94 |
Why?
| Mice, Inbred BALB C | 1 | 1996 | 176 |
Why?
| Biological Markers | 1 | 1996 | 263 |
Why?
| Signal Transduction | 1 | 1996 | 313 |
Why?
|
|
Robert's Networks
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|
